Profiel
Douglas Greene served as the Executive Vice President of Research and Development at Ikaria, Inc. He also worked as the Chief Medical Officer at Sanofi-Aventis Pharmaceuticals for a brief period in 2009.
Eerdere bekende functies van Douglas Greene
| Bedrijven | Functie | Einde |
|---|---|---|
| Sanofi-Aventis Pharmaceuticals | Hoofd Techniek/Wetenschap/O&O | 01-01-2009 |
| IKARIA, INC. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Ikaria, Inc.
 Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
| Sanofi-Aventis Pharmaceuticals |
